Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells

P. C. Braga, G. Piatti

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Azithromycin is the first member of a novel 15-membered-ring 'azalide' group of macrolides that has entered into clinical practice, and its activity is not restricted to gram-positive bacteria, but extends also to gram-negative bacteria. The aim or this study was to investigate the ability of subinhibitory concentrations (sub-MICs) of azithromycin to interfere with the mechanism of bacterial adhesion to human epithelial cells. Azithromycin induced a significant inhibition of adhesion from 1/2 to 1/32 MIC for Staphylococcus aureus and from 1/2 to 1/16 MIC for Escherichia coli. 1/32 of the MIC for S. aureus means 0.048 μg/ml, while 1/16 of the MIC for S. coli means 0.25 μg/ml. At these concentrations no morphological changes in E. coli shape were seen, while sometimes S. aureus cells larger than the normal size appeared. Tissue concentrations of azithromycin decline with an estimated half-life of 2.5-3 days. Since sub-MICs of 0.25 and 0.048 μg/ml are still able to interfere with bacterial physiology, the effective activity of azithromycin, from a pharmacokinetic point of view, could be extended for 3 days beyond the expected period of antimicrobial activity.

Original languageEnglish
Pages (from-to)432-437
Number of pages6
JournalChemotherapy
Volume39
Issue number6
Publication statusPublished - 1993

Fingerprint

Bacterial Adhesion
Azithromycin
Epithelial Cells
Staphylococcus aureus
Bacterial Physiological Phenomena
Escherichia coli
Macrolides
Gram-Positive Bacteria
Gram-Negative Bacteria
Half-Life
Pharmacokinetics

Keywords

  • Azithromycin
  • Escherichia coli
  • Inhibition of adhesivity
  • Staphylococcus aureus
  • Sub-MICs

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells. / Braga, P. C.; Piatti, G.

In: Chemotherapy, Vol. 39, No. 6, 1993, p. 432-437.

Research output: Contribution to journalArticle

@article{304e1e1ab7634474b5595b0cc5c371d8,
title = "Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells",
abstract = "Azithromycin is the first member of a novel 15-membered-ring 'azalide' group of macrolides that has entered into clinical practice, and its activity is not restricted to gram-positive bacteria, but extends also to gram-negative bacteria. The aim or this study was to investigate the ability of subinhibitory concentrations (sub-MICs) of azithromycin to interfere with the mechanism of bacterial adhesion to human epithelial cells. Azithromycin induced a significant inhibition of adhesion from 1/2 to 1/32 MIC for Staphylococcus aureus and from 1/2 to 1/16 MIC for Escherichia coli. 1/32 of the MIC for S. aureus means 0.048 μg/ml, while 1/16 of the MIC for S. coli means 0.25 μg/ml. At these concentrations no morphological changes in E. coli shape were seen, while sometimes S. aureus cells larger than the normal size appeared. Tissue concentrations of azithromycin decline with an estimated half-life of 2.5-3 days. Since sub-MICs of 0.25 and 0.048 μg/ml are still able to interfere with bacterial physiology, the effective activity of azithromycin, from a pharmacokinetic point of view, could be extended for 3 days beyond the expected period of antimicrobial activity.",
keywords = "Azithromycin, Escherichia coli, Inhibition of adhesivity, Staphylococcus aureus, Sub-MICs",
author = "Braga, {P. C.} and G. Piatti",
year = "1993",
language = "English",
volume = "39",
pages = "432--437",
journal = "Chemotherapy",
issn = "0009-3157",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells

AU - Braga, P. C.

AU - Piatti, G.

PY - 1993

Y1 - 1993

N2 - Azithromycin is the first member of a novel 15-membered-ring 'azalide' group of macrolides that has entered into clinical practice, and its activity is not restricted to gram-positive bacteria, but extends also to gram-negative bacteria. The aim or this study was to investigate the ability of subinhibitory concentrations (sub-MICs) of azithromycin to interfere with the mechanism of bacterial adhesion to human epithelial cells. Azithromycin induced a significant inhibition of adhesion from 1/2 to 1/32 MIC for Staphylococcus aureus and from 1/2 to 1/16 MIC for Escherichia coli. 1/32 of the MIC for S. aureus means 0.048 μg/ml, while 1/16 of the MIC for S. coli means 0.25 μg/ml. At these concentrations no morphological changes in E. coli shape were seen, while sometimes S. aureus cells larger than the normal size appeared. Tissue concentrations of azithromycin decline with an estimated half-life of 2.5-3 days. Since sub-MICs of 0.25 and 0.048 μg/ml are still able to interfere with bacterial physiology, the effective activity of azithromycin, from a pharmacokinetic point of view, could be extended for 3 days beyond the expected period of antimicrobial activity.

AB - Azithromycin is the first member of a novel 15-membered-ring 'azalide' group of macrolides that has entered into clinical practice, and its activity is not restricted to gram-positive bacteria, but extends also to gram-negative bacteria. The aim or this study was to investigate the ability of subinhibitory concentrations (sub-MICs) of azithromycin to interfere with the mechanism of bacterial adhesion to human epithelial cells. Azithromycin induced a significant inhibition of adhesion from 1/2 to 1/32 MIC for Staphylococcus aureus and from 1/2 to 1/16 MIC for Escherichia coli. 1/32 of the MIC for S. aureus means 0.048 μg/ml, while 1/16 of the MIC for S. coli means 0.25 μg/ml. At these concentrations no morphological changes in E. coli shape were seen, while sometimes S. aureus cells larger than the normal size appeared. Tissue concentrations of azithromycin decline with an estimated half-life of 2.5-3 days. Since sub-MICs of 0.25 and 0.048 μg/ml are still able to interfere with bacterial physiology, the effective activity of azithromycin, from a pharmacokinetic point of view, could be extended for 3 days beyond the expected period of antimicrobial activity.

KW - Azithromycin

KW - Escherichia coli

KW - Inhibition of adhesivity

KW - Staphylococcus aureus

KW - Sub-MICs

UR - http://www.scopus.com/inward/record.url?scp=0027422837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027422837&partnerID=8YFLogxK

M3 - Article

C2 - 8222872

AN - SCOPUS:0027422837

VL - 39

SP - 432

EP - 437

JO - Chemotherapy

JF - Chemotherapy

SN - 0009-3157

IS - 6

ER -